+ A
A -
Tribune News Network
Doha
The Ministry of Public Health (MoPH), in collaboration with Hamad Medical Corporation and Sanofi, recently organised a two-day educational scientific programme led by renowned national and international experts.
Participating cardiologists and endocrinologists emphasised the need for adopting effective and timely measures to ensure improved domestic cholesterol management in patients to address cardiovascular disease risk.
The programme included scientific presentations on dyslipidemia management, guidelines for lipid management, updates on latest therapy advancements and advanced workshops on optimal management based on case studies.
Experts noted a large number of patients are faced with the challenge of achieving the recommended LDL cholesterol levels. During the sessions, experts deliberated on the unmet need for additional LDL-C lowering therapy and the potential role of PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibition in the future lipid management to prevent cardiovascular disease and manage familial hypercholesterolemia (FH) cases. PCSK9 is a protein that plays a critical role in the modulation of LDL-C levels in the blood.
"The Ministry of Public Health, through the National Health Strategy, emphasises the importance of medical education programmes to develop highly skilled workforce. This is essential if we are to successfully implement our public health agenda and reduce the incidence of chronic diseases. Our effort is to better equip our health experts, enhance their knowledge on latest scientific advancements and enable physicians to deliver the best health outcomes for patients," said Dr Salih Ali al Marri.
He added,"An internationally recognised quality improvement framework with the triple aim of Better Health, Better Care and Better Value is being adopted for NHS 2017-2022. Collaborative public-private partnerships will be key to achieving our healthcare goals and securing the future of the country."
Dr Mahmoud A Zirie, senior consultant Endocrinology, head of Endocrinology and Diabetes at Hamad Hospital, said:"People with underlying conditions such as high blood pressure (hypertension) and diabetes often have high cholesterol. In the region, adults also suffer from familial hypercholesterolemia (FH), a little known inherited condition associated with high cholesterol that can result in early cardiovascular disease."
